APA (7th ed.) Citation

Remmerie, M., Dok, R., Wang, Z., Omella, J. D., Alen, S., Cokelaere, C., . . . Janssens, V. (2024). The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism. Cellular Oncology, 47(5), 1811. https://doi.org/10.1007/s13402-024-00963-5

Chicago Style (17th ed.) Citation

Remmerie, Michiel, et al. "The PPP2R1A Cancer Hotspot Mutant P.R183W Increases Clofarabine Resistance in Uterine Serous Carcinoma Cells by a Gain-of-function Mechanism." Cellular Oncology 47, no. 5 (2024): 1811. https://doi.org/10.1007/s13402-024-00963-5.

MLA (9th ed.) Citation

Remmerie, Michiel, et al. "The PPP2R1A Cancer Hotspot Mutant P.R183W Increases Clofarabine Resistance in Uterine Serous Carcinoma Cells by a Gain-of-function Mechanism." Cellular Oncology, vol. 47, no. 5, 2024, p. 1811, https://doi.org/10.1007/s13402-024-00963-5.